Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Guowei Wu

Showing results (131-140 of 135) with videos related to

Pageof 14
Sort By:
You have reached the last page of results.This site can display upto 135 results.
Psychiatry Research|October 17, 2022
Sex difference in the prevalence of psychotic-like experiences in adolescents: results from a pooled study of 21,248 Chinese participantsZhipeng Wu, Dayi Liu, Jiamei Zhang, et al.
Cell Discovery|June 2, 2021
Discovery of a cooperative mode of inhibiting RIPK1 kinaseHuyan Meng, Guowei Wu, Xinsuo Zhao, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 21, 2023
Small molecule activators of TAK1 promotes its activity-dependent ubiquitination and TRAIL-mediated tumor cell deathWeimin Sun, Guowei Wu, Xinyu Tian, et al.
Cell Chemical Biology|February 27, 2018
SRPKIN-1: A Covalent SRPK1/2 Inhibitor that Potently Converts VEGF from Pro-angiogenic to Anti-angiogenic IsoformJohn M Hatcher, Guowei Wu, Chuyue Zeng, et al.
Cell Research|October 19, 2021
SARS-CoV-2 promotes RIPK1 activation to facilitate viral propagationGang Xu, Ying Li, Shengyuan Zhang, et al.
Pageof 14

Showing results (131-140 of 135) with videos related to

Sort By:
Pageof 14
You have reached the last page of results.This site can display upto 135 results.
Psychiatry Research|October 17, 2022
Sex difference in the prevalence of psychotic-like experiences in adolescents: results from a pooled study of 21,248 Chinese participantsZhipeng Wu, Dayi Liu, Jiamei Zhang, et al.
Cell Discovery|June 2, 2021
Discovery of a cooperative mode of inhibiting RIPK1 kinaseHuyan Meng, Guowei Wu, Xinsuo Zhao, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 21, 2023
Small molecule activators of TAK1 promotes its activity-dependent ubiquitination and TRAIL-mediated tumor cell deathWeimin Sun, Guowei Wu, Xinyu Tian, et al.
Cell Chemical Biology|February 27, 2018
SRPKIN-1: A Covalent SRPK1/2 Inhibitor that Potently Converts VEGF from Pro-angiogenic to Anti-angiogenic IsoformJohn M Hatcher, Guowei Wu, Chuyue Zeng, et al.
Cell Research|October 19, 2021
SARS-CoV-2 promotes RIPK1 activation to facilitate viral propagationGang Xu, Ying Li, Shengyuan Zhang, et al.
Pageof 14